omalizumab for asthma special

Omalizumab (Xolair) is a medicine approved by the U.S. Food and Drug Administration (FDA) for use in people age 12 and older who have moderate or severe persistent asthma. This medicine costs a lot more than any of the standard treatments for asthma. The medicine works by blocking immunoglobulin E (IgE) from attaching...